International Edition
Latest News
Health

Time-in-range >70% Linked to 88.54% Patency After DFO Endovascular Therapy

Diabetic patients with time in range above 70% achieved 88.54% primary patency at 12 months after endovascular therapy for femoropopliteal artery occlusion. Time in range glucose targets above 70% improve 12-month primary patency rates after endovascular therapy for…

Diabetic patients with time in range above 70% achieved 88.54% primary patency at 12 months after endovascular therapy for femoropopliteal artery occlusion.

Time in range glucose targets above 70% improve 12-month primary patency rates after endovascular therapy for diabetic femoropopliteal artery occlusion.

Researchers evaluated 162 patients with diabetic femoropopliteal artery occlusion in a prospective cohort study. Investigators split participants into two groups based on seven-point glucose profiles recorded within seven days.

The study compared patients with a time in range below 70% against those with a time in range above 70%. These groups showed distinct differences in glycemic control metrics and subsequent vascular healing.

Patients with a time in range below 70% recorded an average time in range value of 58.84 ± 7.72%. Participants with a time in range above 70% achieved an average value of 78.34 ± 6.13%.

The primary patency rate at 12 months reached 71.67% in the lower time in range group. In contrast, the group with a time in range above 70% attained a primary patency rate of 88.54%.

Restenosis rates climbed to 28.33% for patients with lower glycemic control. Patients in the higher time in range group experienced a restenosis rate of 11.46%.

Endovascular Therapy Outcomes by Glucose Time in Range
Clinical Parameter TIR Below 70% Group TIR Above 70% Group
Time in Range Value 58.84 ± 7.72% 78.34 ± 6.13%
12-Month Primary Patency 71.67% 88.54%
Restenosis Rate 28.33% 11.46%
Target Lesion Revascularization 23.33% 8.33%

Clinically-driven target lesion revascularization occurred in 23.33% of patients with a time in range below 70%. Only 8.33% of patients in the higher time in range group required this intervention.

Severe calcification carried a hazard ratio of 4.08 with a 95% confidence interval ranging from 1.86 to 8.97. Time in range registered an independent hazard ratio of 0.025 with a 95% confidence interval from 0.001 to 0.70.

These statistical evaluations confirmed both severe calcification and time in range as independent risk factors for restenosis after endovascular therapy.

About the author: Health Desk

Health Desk at Archynewsy.